相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Highlights from the latest articles in nanomedicine for reproductive oncology
Celine Jones et al.
NANOMEDICINE (2015)
MicroRNA-338 inhibits migration and proliferation by targeting hypoxia-induced factor 1α in nasopharyngeal carcinoma
Ying Shan et al.
ONCOLOGY REPORTS (2015)
Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost
Xiaomin Ou et al.
ONCOTARGET (2015)
DTX-loaded star-shaped TAPP-PLA-b-TPGS nanoparticles for cancer chemical and photodynamic combination therapy
Teng Wang et al.
RSC ADVANCES (2015)
Overview on in vitro and in vivo investigations of nanocomposite based cancer diagnosis and therapeutics
A. P. Subramanian et al.
RSC ADVANCES (2015)
Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis
Rui-Cheng Ji
CANCER LETTERS (2014)
Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer
Xue-Pu Sun et al.
FEBS JOURNAL (2014)
Expression of HIF-1α and CAIX in nasopharyngeal carcinoma and their correlation with patients' prognosis
Yuhan Chen et al.
MEDICAL ONCOLOGY (2014)
Properties and energetics for design and characterization of chitosan nanoparticles used for drug encapsulation
Emmanuel N. Koukaras et al.
RSC ADVANCES (2014)
Hypoxia Induced Multidrug Resistance of Laryngeal Cancer Cells via Hypoxia-inducible Factor-1α
Da-Wei Li et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer
Xiaowei Zeng et al.
BIOMATERIALS (2013)
Chitosan-coated PLGA nanoparticles: A sustained drug release strategy for cell cultures
Laura Chronopoulou et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
Improvement of therapeutic efficacy of PLGA nanoformulation of siRNA targeting anti-apoptotic Bcl-2 through chitosan coating
Hitesh Vitthalbhai Jagani et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Hypoxia-inducible factor-1 as a therapeutic target in cancer
Ceen-Ming Tang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape
Jerome Gilleron et al.
NATURE BIOTECHNOLOGY (2013)
Hypoxia-Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
Jennifer Adamski et al.
PLOS ONE (2013)
Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1
X. L. Dong et al.
BIOMEDICINE & PHARMACOTHERAPY (2012)
Design of an inhalable dry powder formulation of DOTAP-modified PLGA nanoparticles loaded with siRNA
Ditte Krohn Jensen et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Vitamin E D-α-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine
Zhiping Zhang et al.
NANOMEDICINE (2012)
Valproic acid overcomes hypoxia-induced resistance to apoptosis
Simon Cipro et al.
ONCOLOGY REPORTS (2012)
Revisiting the ABCs of Multidrug Resistance in Cancer Chemotherapy
Amit K. Tiwari et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Cationic nanoparticles for cancer therapy
Erem Bilensoy
EXPERT OPINION ON DRUG DELIVERY (2010)
Cancer, chitosan nanoparticles and catalytic nucleic acids
Mei Lin Tan et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Mark E. Davis et al.
NATURE (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells
J. Hao et al.
CANCER GENE THERAPY (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs
Constantina Constantinou et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy
Kyung Hyun Min et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Vitamin E analogs, a novel group of mitocans, as anticancer agents: The importance of being redox-silent
Jiri Neuzil et al.
MOLECULAR PHARMACOLOGY (2007)
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS:: Influence on ATPase activity and membrane fluidity
Eva-Maria Collnot et al.
MOLECULAR PHARMACEUTICS (2007)
Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene
Xianrang Song et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol
HJ Youk et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance
JT Erler et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The hypoxia-inducible factor-1α is a negative factor for tumor therapy
A Unruh et al.
ONCOGENE (2003)
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
J Panyam et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)